B. Metzler seel. Sohn & Co. AG Raises Holdings in Cardinal Health, Inc. $CAH

Key Points

• B. Metzler seel. Sohn & Co. AG more than doubled its Cardinal Health stake in the second quarter, increasing holdings by 111.8% to 26,592 shares valued at approximately $6.3 million.
• Institutional investors own 87.17% of Cardinal Health, while insiders have recently sold heavily; executives sold 210,271 shares worth about $49.6 million over the past 90 days.
• Cardinal Health beat quarterly earnings expectations with EPS of $2.91 versus $2.42 forecast, announced a $0.5158 quarterly dividend, and maintains a Moderate Buy consensus rating with a $266.56 average analyst price target.

B. Metzler seel. Sohn & Co. AG lifted its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 111.8% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 26,592 shares of the company's stock after purchasing an additional 14,039 shares during the quarter. B. Metzler seel. Sohn & Co. AG's holdings in Cardinal Health were worth $6,317,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Integrated Wealth Concepts LLC grew its position in Cardinal Health by 6.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company's stock worth $601,000 after purchasing an additional 280 shares during the last quarter. Jones Financial Companies Lllp raised its holdings in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock worth $27,000 after buying an additional 14,034 shares during the last quarter. Arrowstreet Capital Limited Partnership purchased a new position in shares of Cardinal Health in the second quarter worth $1,935,000. Cerity Partners LLC lifted its stake in shares of Cardinal Health by 17.0% during the second quarter. Cerity Partners LLC now owns 40,426 shares of the company's stock worth $6,792,000 after buying an additional 5,880 shares during the period. Finally, Nebula Research & Development LLC lifted its stake in shares of Cardinal Health by 34.4% during the second quarter. Nebula Research & Development LLC now owns 10,334 shares of the company's stock worth $1,736,000 after buying an additional 2,646 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Michelle D. Greene sold 11,650 shares of the firm's stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $235.72, for a total transaction of $2,746,138.00. Following the sale, the insider owned 10,330 shares in the company, valued at approximately $2,434,987.60. This trade represents a 53.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Stephen M. Mason sold 35,000 shares of Cardinal Health stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $236.40, for a total transaction of $8,274,000.00. Following the completion of the transaction, the chief executive officer directly owned 18,061 shares of the company's stock, valued at $4,269,620.40. The trade was a 65.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 210,271 shares of company stock worth $49,626,657. 0.12% of the stock is currently owned by corporate insiders.

Cardinal Health Stock Up 1.4%

Shares of CAH opened at $248.88 on Friday. The company has a market capitalization of $57.88 billion, a price-to-earnings ratio of 34.42, a PEG ratio of 1.48 and a beta of 0.51. Cardinal Health, Inc. has a 52 week low of $145.87 and a 52 week high of $258.30. The stock's 50-day moving average price is $234.06 and its 200-day moving average price is $218.99.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, beating the consensus estimate of $2.42 by $0.49. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The company had revenue of $63.67 billion during the quarter, compared to analysts' expectations of $65.15 billion. During the same period last year, the business earned $2.08 earnings per share. Cardinal Health's quarterly revenue was up 5.8% on a year-over-year basis. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 12.55 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be issued a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health's payout ratio is 28.49%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on CAH shares. UBS Group upped their target price on Cardinal Health from $274.00 to $280.00 and gave the company a "buy" rating in a research report on Wednesday, August 12th. Bank of America lifted their price target on Cardinal Health from $240.00 to $260.00 and gave the stock a "buy" rating in a research report on Thursday, July 2nd. TD Cowen boosted their price target on Cardinal Health from $275.00 to $280.00 and gave the company a "buy" rating in a research note on Thursday, August 13th. JPMorgan Chase & Co. increased their price objective on Cardinal Health from $215.00 to $260.00 and gave the company a "neutral" rating in a report on Thursday, August 13th. Finally, Wall Street Zen upgraded Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, July 4th. Sixteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Cardinal Health has a consensus rating of "Moderate Buy" and a consensus target price of $266.56.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source